It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2021.
2021 | Mumbai, Maharashtra, India | ActiveDaivat Lifesciences Private Limited, a active private limited company, was established on 21 April 2021 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MH2021PTC359283. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Tejas Champaklal Shah (Director), Manan Mukesh Parikh (Director). Past directors included Nirav Vikram Maniar, Tejas Champaklal Shah, Purvesh Nirav Maniar. It holds ₹22.00 Cr open charges and ₹17.45 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-301, Kailash Tower ,Behind Stc Society N S Phadke Marg, Andheri (East), Mumbai, Maharashtra, 400069.
U51909MH2021PTC359283
359283
21 April 2021
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Daivat Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tejas Champaklal Shah | Director | 04 Aug 2023 | Current |
| Manan Mukesh Parikh | Director | 21 Apr 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Aug 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Daivat Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 187.3% increase. The company also saw a substantial improvement in profitability, with a 107.26% increase in profit. The company's net worth Soared by an impressive increase of 166.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Daivat Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹220,000,000.00
₹174,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Oct 2024 | Axis Bank Limited | ₹22.00 Cr | Open |
| 09 Jun 2022 | Others | ₹12.50 Cr | Satisfied |
| 30 Oct 2021 | State Bank Of India | ₹4.95 Cr | Satisfied |
Explore comprehensive loan charge details -
Daivat Lifesciences has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Daivat Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daivat Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 09 Jun 2022 via Charge ID 100582787 with Others was fully satisfied on 05 Nov 2024. was recorded as a recent event.
Progress on A charge with Axis Bank Limited amounted to Rs. 220.00 M with Charge ID 101004742 was registered on 07 Oct 2024. was documented.
Progress on Daivat Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Daivat Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Others of Rs. 125.00 M registered on 09 Jun 2022 with Charge ID 100582787 was modified on 07 Oct 2023. was documented.
The activity Tejas Champaklal Shah was appointed as a Director was appointed as a Director on 04 Aug 2023 & has been associated with this company since 2 years 3 months . was completed.
The CIN of Daivat Lifesciences Private Limited is U51909MH2021PTC359283.
Daivat Lifesciences Private Limited is headquartered at A-301, Kailash Tower ,Behind Stc Society N S Phadke Marg, Andheri (East), Mumbai, Maharashtra, 400069.
Daivat Lifesciences Private Limited was incorporated on 21 April 2021.
The current directors of Daivat Lifesciences Private Limited are
The primary industry of Daivat Lifesciences Private Limited is Trade.
Daivat Lifesciences Private Limited is unlisted.
The authorized capital of Daivat Lifesciences Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX